Dimensional Fund Advisors Lp ownership in PCRX / Pacira BioSciences, Inc.

Pacira BioSciences, Inc.

US ˙ NasdaqGS ˙ US6951271005

Security	PCRX / Pacira BioSciences, Inc.
Institution	Dimensional Fund Advisors Lp
Latest Disclosed Ownership	2,060,597 shares
Ownership	5.10%

2026-04-09 - Dimensional Fund Advisors Lp has filed an SCHEDULE 13G form with the Securities and Exchange Commission (SEC) disclosing ownership of 2,060,597 shares of Pacira BioSciences, Inc. (US:PCRX). This represents 5.1 percent ownership of the company.

Institutional Ownership: 13D/G Filings

This table shows a history of the 13D/G filings made by the investor and/or investor group. Note that the share values in this table are not directly comparable to any numbers shown in the 13F table (if any).

File Date	Effective Date	Form	Prev Shares	Latest Shares	ΔShares (Percent)	Ownership (Percent)	ΔOwnership (Percent)
2026-04-09	2026-04-09	13G		2,060,597		5.10

Important Note: One of the primary uses of the 13D/G filings is to evaluate the ability of a firm to control a company (ie, the "beneficial ownership"). To that end, firms are required to report not just direct holdings in companies, but indirect holdings that they control. For investment firms, these indirect holdings can include shares in funds they manage, advisory accounts, and in the case of activist campaigns, pledged votes. Therefore, share counts listed in 13D/G filings can differ significantly than share counts listed in 13F filings.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel Premium Registration Required .

Disclosed Equity Positions (from 13F/NPORT Filings)

File Date	Effective Date	Form	Security	Class	ID	Reported Shares	ΔShares	ΔShares (%)	Reported Value (x1000)	ΔValue (%)	Alloc (%)
2026-05-07	2026-03-31	13F	PACIRA BIOSCIENCES	COM	695127100	2,060,597	110,584	5.67	46,572	-7.72	0.0021
2026-02-12	2025-12-31	13F	PACIRA BIOSCIENCES	COM	695127100	1,950,013	-213,460	-9.87	50,467	-9.48	0.0106
2025-11-12	2025-09-30	13F	PACIRA BIOSCIENCES	COM	695127100	2,163,473	11,831	0.55	55,751	8.42	0.0120
2025-08-12	2025-06-30	13F	PACIRA BIOSCIENCES	COM	695127100	2,151,642	102,211	4.99	51,423	0.97	0.0119
2025-05-13	2025-03-31	13F	PACIRA BIOSCIENCES	COM	695127100	2,049,431	217,215	11.86	50,928	47.53	0.0127
2025-02-13	2024-12-31	13F	PACIRA BIOSCIENCES	COM	695127100	1,832,216	-40,154	-2.14	34,519	22.51	0.0083
2024-11-07	2024-09-30	13F	PACIRA BIOSCIENCES	COM	695127100	1,872,370	44,305	2.42	28,178	-46.12	0.0068
2024-08-09	2024-06-30	13F	PACIRA BIOSCIENCES	COM	695127100	1,828,065	198,936	12.21	52,300	9.86	0.0137
2024-05-10	2024-03-31	13F	PACIRA BIOSCIENCES	COM	695127100	1,629,129	217,362	15.40	47,603	-0.06	0.0129
2024-02-07	2023-12-31	13F	PACIRA BIOSCIENCES	COM	695127100	1,411,767	17,949	1.29	47,633	11.39	0.0139
2023-11-09	2023-09-30	13F	PACIRA BIOSCIENCES	COM	695127100	1,393,818	271,544	24.20	42,763	-4.90	0.0140
2023-08-09	2023-06-30	13F	PACIRA BIOSCIENCES	COM	695127100	1,122,274	133,097	13.46	44,969	11.40	0.0143
2023-05-12	2023-03-31	13F	PACIRA BIOSCIENCES	COM	695127100	989,177	41,808	4.41	40,367	112,030.56	0.0136
2023-02-09	2022-12-31	13F	PACIRA BIOSCIENCES	COM	695127100	947,369	70,141	8.00	37	-99.92	0.0108
2022-11-10	2022-09-30	13F	PACIRA BIOSCIENCES	COM	695127100	877,228	67,892	8.39	46,662	-1.11	0.0179
2022-08-12	2022-06-30	13F	PACIRA BIOSCIENCES	COM	695127100	809,336	50,941	6.72	47,185	-18.48	0.0169
2022-05-13	2022-03-31	13F	PACIRA BIOSCIENCES	COM	695127100	758,395	3,602	0.48	57,880	27.44	0.0178
2022-02-09	2021-12-31	13F	PACIRA BIOSCIENCES	COM	695127100	754,793	40,191	5.62	45,417	13.49	0.0137
2021-11-12	2021-09-30	13F	PACIRA BIOSCIENCES	COM	695127100	714,602	-68,290	-8.72	40,019	-15.76	0.0129
2021-08-12	2021-06-30	13F	PACIRA BIOSCIENCES	COM	695127100	782,892	169,324	27.60	47,506	10.46	0.0150
2021-05-14	2021-03-31	13F	PACIRA BIOSCIENCES	COM	695127100	613,568	37,851	6.57	43,006	24.84	0.0142
2021-03-08	2020-12-31	13F/A-2	PACIRA BIOSCIENCES	COM	695127100	575,717	18,553	3.33	34,449	2.85	0.0124
2021-02-11	2020-12-31	13F	PACIRA BIOSCIENCES	COM	695127100	575,717	18,553		34,449		12,441.1477
2020-11-12	2020-09-30	13F	PACIRA BIOSCIENCES	COM	695127100	557,164	12,857	2.36	33,495	17.28	0.0142
2020-08-13	2020-06-30	13F	PACIRA BIOSCIENCES	COM	695127100	544,307	15,972	3.02	28,559	61.21	0.0126
2020-05-14	2020-03-31	13F	PACIRA BIOSCIENCES	COM	695127100	528,335	22,550	4.46	17,715	-22.68	0.0092
2020-02-14	2019-12-31	13F	PACIRA BIOSCIENCES	COM	695127100	505,785	2,941	0.58	22,911	19.66	0.0083
2019-11-12	2019-09-30	13F	PACIRA BIOSCIENCES	COM	695127100	502,844	77,525	18.23	19,146	3.50	0.0074
2019-08-13	2019-06-30	13F	PACIRA BIOSCIENCES	COM	695127100	425,319	73,207	20.79	18,498	38.03	0.0072
2019-08-12	2019-03-31	13F/A-2	PACIRA PHARMACEUTICALS	COM	695127100	352,112	111,505	46.34	13,401	29.47	0.0053
2019-05-10	2019-03-31	13F	PACIRA PHARMACEUTICALS	COM	695127100	352,112	111,505		13,401
2019-02-26	2018-12-31	13F/A-1	PACIRA PHARMACEUTICALS	COM	695127100	240,607	180,425	299.80	10,351	249.93	0.0047
2019-02-13	2018-12-31	13F	PACIRA PHARMACEUTICALS	COM	695127100	240,607	180,425		10,351
2018-11-13	2018-09-30	13F	PACIRA PHARMACEUTICALS	COM	695127100	60,182	60,182		2,958		0.0011
2015-08-14	2015-06-30	13F	PACIRA PHARMACEUTICALS	COM	695127100	0	-46,790	-100.00	0	-100.00
2015-05-14	2015-03-31	13F	PACIRA PHARMACEUTICALS	COM	695127100	46,790	-3,270	-6.53	4,157	-6.33	0.0026
2015-02-06	2014-12-31	13F	PACIRA PHARMACEUTICALS	COM	695127100	50,060	22,094	79.00	4,438	63.76	0.0029
2014-11-13	2014-09-30	13F	PACIRA PHARMACEUTICALS	COM	695127100	27,966	19,962	249.40	2,710	268.71	0.0019
2014-08-08	2014-06-30	13F	PACIRA PHARMACEUTICALS	COM	695127100	8,004	8,004		735		0.0005

Legend

Shares: The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value: The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price: The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class: This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred

Allocation (%): The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation: The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%): The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis: The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss: This is the market value of the position as of the effective date minus the cost basis.